AcuityMD Archives - Medical Design Sourcing

Could minimally invasive neuromod tackle the opioid epidemic?

The Sparrow therapy system. [Image from Spark Biomedical] Officials at Spark Biomedical and AcuityMD think their partnership could accelerate the commercialization of Spark’s potentially game-changing platform.

Spark Biomedical develops a topical, minimally invasive medical device for alleviating opioid withdrawal symptoms. AcuityMD has a platform for helping medical device companies accelerate commercial access to their products.

Together, they seek to provide a pathway to life-restoring sobriety for millions suffering from opioid addiction. Last month, Spark and AcuityMD announced a partnership to accelerate the expansion of the former’s technology. The FDA-approved Sparrow therapy system represents a drug-free tool for helping treat opioid use disorder. It sends mild electrical impulses to the brain to help alleviate withdrawal symptoms.

AcuityMD’s data-driven commercial platform supports this expansion effort. It helps

“We saw an op…

Could minimally invasive neuromod tackle the opioid epidemic?

The Sparrow therapy system. [Image from Spark Biomedical]

Officials at Spark Biomedical and AcuityMD think their partnership could accelerate the commercialization of Spark’s potentially game-changing platform.

Spark Biomedical develops a topical, minimally invasive medical device for alleviating opioid withdrawal symptoms. AcuityMD has a platform for helping medical device companies accelerate commercial access to their products.

Together, they seek to provide a pathway to life-restoring sobriety for millions suffering from opioid addiction. Last month, Spark and AcuityMD announced a partnership to accelerate the expansion of the former’s technology. The FDA-approved Sparrow therapy system represents a drug-free tool for helping treat opioid use disorder. It sends mild electrical impulses to the brain to help alleviate withdrawal symptoms.

AcuityMD’s data-driven commercial platform suppo…

Device commercialization platform AcuityMD raises $31M Series A to fund R&D engineer hiring

AcuityMD co-founder and CEO Michael Monovoukas [Photo courtesy of AcuityMD]

AcuityMD said today it has raised $31 million in Series A funding for its medical device commercialization platform.

“With our new funding, we plan to double down on R&D by growing our engineering team from 15 to over 40 over the next year,” AcuityMD co-founder and CEO Michael Monovoukas said in a blog post. “We’ll also make our first go-to-market hires in sales and marketing and build out these new functions to supercharge our growth.”

Monovoukas said his company’s customers — which include Anika Therapeutics, ConMed, Cordis, and Olympus — “have identified over 40,000 new opportunities using our software, which translates to over $2 billion in new annual pipeline.”

AcuityMD’s web-based software and data platform integrates prop…